A Safety and Tolerability Single Ascending Dose Study in Healthy Volunteers
NCT00583544
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
TC-2216
Sponsor
Targacept Inc.